1-8 of 8
Susan Lerner, M.S.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frontline Combined Chemoimmunotherapy with Fludarabine, Cyclophosphamide, Alemtuzumab and Rituximab (CFAR) in High-Risk Chronic Lymphocytic Leukemia.

Sameer A Parikh, MD, Michael Keating, MD, Susan O'Brien, Alessandra Ferrajoli, Stefan Faderl, MD, Charles Koller, MD, Zeev Estrov, Susan Lerner, M.S., RHIA, William G. Wierda, M.D., Ph.D
Journal: Blood
Blood (2009) 114 (22): 208.
https://doi.org/10.1182/blood.V114.22.208.208
Published: 2009
Journal Articles

Long Term Outcome Following Treatment Failure of FCR Chemoimmunotherapy as Initial Therapy for Chronic Lymphocytic Leukemia.

Michael J. Keating, M.B., B.S., William G. Wierda, M.D., Ph.D, Constantine S. Tam, M.B., B.S., Alice Lynn, Susan O'Brien, M.D., Susan Lerner, M.S., RHIA, Hagop M. Kantarjian, M.D.
Journal: Blood
Blood (2009) 114 (22): 2381.
https://doi.org/10.1182/blood.V114.22.2381.2381
Published: 2009
Journal Articles

Pretreatment Factors Associated with Second Malignancies Occuring After Frontline Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Patients with Chronic Lymphocytic Leukemia (CLL).

Nicolas Batty, MD, Xavier C. Badoux, MBBS, Michael Keating, MD, E. Lin, Susan Lerner, M.S., RHIA, Susan O'Brien, Alessandra Ferrajoli, MD., Tapan Kadia, MD, Jan A. Burger, MD, PhD, Stefan Faderl, MD, William G. Wierda, M.D., Ph.D
Journal: Blood
Blood (2009) 114 (22): 3448.
https://doi.org/10.1182/blood.V114.22.3448.3448
Published: 2009
Journal Articles

Treatment Effect of First Line Rituximab, Fludarabine and Cyclosphosphamide in a Chronic Lymphocytic Leukemia Patient Cohort: An Evaluation of Prognostic Factors, Estimated Life Expectancy and Economic Outcomes

Emma Carr, PhD, Susan Lerner, M.S., RHAI, Rick Aultman, MSc, Ute Weisgerber-Kriegl, PhD, Michael Keating, MB, BS
Journal: Blood
Blood (2008) 112 (11): 2396.
https://doi.org/10.1182/blood.V112.11.2396.2396
Published: 2008
Journal Articles

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Analysis of 2083 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Susan O’Brien, M.D., Peter McLaughlin, M.D., Sijin Wen, M.S., William Wierda, M.D., Ph.D., Hagop M. Kantarjian, M.D., John Manning, M.D., Susan Lerner, M.S., Mark Hess, B.B.A., Emil J. Freireich, M.D., Michael J. Keating, M.D.
Journal: Blood
Blood (2006) 108 (11): 2790.
https://doi.org/10.1182/blood.V108.11.2790.2790
Published: 2006
Journal Articles

A Prognostic Score for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Analysis of 2189 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Peter McLaughlin, M.D., Susan O’Brien, M.D., Sijin Wen, M.S., William G. Wierda, M.D., Ph.D., John Manning, M.D., Susan Lerner, M.S., Mark A. Hess, Hagop Kantarjian, M.D., Emil J. Freireich, M.D., Michael J. Keating, M.D.
Journal: Blood
Blood (2006) 108 (11): 2783.
https://doi.org/10.1182/blood.V108.11.2783.2783
Published: 2006
Journal Articles

Combination of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Richter’s Syndrome and Fludarabine-Refractory Chronic Lymphocytic Leukemia.

Apostolia-Maria Tsimberidou, MD, PhD, William G. Wierda, M.D., Ph.D., Susan O’Brien, M.D., William W. Plunkett, M.D., Thomas J. Kipps, M.D., Jennifer R. Brown, M.D., Ph.D, Susan Lerner, M.S., Hagop Kantarjian, M.D., Michael J. Keating, M.D.
Journal: Blood
Blood (2006) 108 (11): 2825.
https://doi.org/10.1182/blood.V108.11.2825.2825
Published: 2006
Journal Articles

Genomic Aberrations in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma by Absolute Lymphocyte Count: Analysis of 1694 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Peter McLaughlin, M.D., Susan O’Brien, M.D., Sijin Wen, M.S., William G. Wierda, M.D., Ph.D., John T. Manning, M.D., Lynne V. Abruzzo, M.D., Ph.D., Susan Lerner, M.S., Mark A. Hess, B.B.A., Hagop M. Kantarjian, M.D., Emil J. Freireich, M.D., Michael J. Keating, M.D.
Journal: Blood
Blood (2006) 108 (11): 4958.
https://doi.org/10.1182/blood.V108.11.4958.4958
Published: 2006